Skip to main content
. 2024 Nov 29;14:1478672. doi: 10.3389/fonc.2024.1478672

Figure 4.

Figure 4

PRMT5 was a negative regulator in LC prognosis. (A, B) OS and DFS analysis of PRMT5 in GSE30219. (C) Univariate cox regression analysis of PRMT5 could act as an independent prognostic biomarker. (D) ROC of PRMT5 at predicting 1-, 3-, and 5-year overall survival.